π€ AI Summary
This work addresses a critical limitation in existing medication recommendation methods, which treat co-prescribed drugs as independent entities and thus fail to capture their collective therapeutic effects, leading to recommendations misaligned with patientsβ long-term clinical trajectories. To overcome this, the authors propose a two-stage cross-level abstraction framework that leverages a multi-head graph reasoning mechanism to aggregate daily medications into clinically meaningful semantic units. This framework enables cross-hierarchical feature propagation between historical prescriptions and candidate drugs, explicitly modeling the synergistic effects of drug combinations for the first time in recommendation systems. By integrating multi-head graph neural networks with multi-level semantic abstraction, the method significantly outperforms state-of-the-art approaches on two real-world clinical datasets, demonstrating the efficacy of structured drug abstraction in enhancing recommendation accuracy.
π Abstract
Historical prescriptions and selected candidate drugs relevant to the current visit serve as important references for medication recommendation. However, in the absence of explicit intrinsic principles for semantic composition, existing methods treat synergistic drugs as independent entities and fail to capture their collective therapeutic effects, resulting in a mismatch between medication-level references and longitudinal patient representations. In this paper, we propose MSAM, a novel medication recommendation model that bridges the gap via multi-level medication abstraction. The model introduces a multi-head graph reasoning mechanism to organize flat daily medication sets into clinically meaningful semantic units, serving as intermediate abstraction results to propagate features from individual drugs to higher-level representations. Building on these units, MSAM performs two-stage abstraction over historical prescriptions and selected candidates via intra- and inter-level feature propagation across heterogeneous clinical structures, capturing collective therapeutic effects aligned with patient conditions. Experiments on two real-world clinical datasets show that MSAM consistently outperforms state-of-the-art methods, validating the effectiveness of structural medication abstraction for recommendation.